We are delighted to be featured on TVB News to highlight a landmark milestone in our journey toward achieving a functional cure for HIV! 

At Yicura BioMed (formerly Immuno Cure), in close collaboration with Prof. Zhiwei Chen and his research team at HKU AIDS Institute and CVVT - Centre for Virology, Vaccinology and Therapeutics, we are pioneering ICVAX® — our novel, PD-1-enhanced therapeutic HIV DNA vaccine designed to empower host immunity and change the paradigm of HIV treatment.

Leveraging our strong partnerships with academia and clinical institutions, Yicura remains committed to bridging cutting-edge research with real-world impact, staying true to our mission of striving to be a leader in immunotherapeutics.

Watch the full TVB coverage:

Chinese: https://bit.ly/4xldHwp

English: https://bit.ly/4hDhhOb

#Yicura #YicuraBioMed #ICVAX #HIV #FunctionalCure #Immunotherapy #HKUMed #CVVT #PhaseII #NMPA #Biotech #Innovation #TherapeuticVaccine #InfectiousDiseases #JID #JournalOfInfectiousDiseases